Picture of Sensorion SA logo

ALSEN — Sensorion SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Sensorion: First Patient Enrolled In Sens-401 Trial For Residual Hearing Preservation During Cochlear Implantation

Sept 14 (Reuters) - Sensorion SA  ALSEN.PA :
    * SENSORION ANNOUNCES FIRST PATIENT ENROLLED IN
PROOF-OF-CONCEPT
CLINICAL TRIAL OF SENS-401 FOR RESIDUAL HEARING PRESERVATION
DURING COCHLEAR IMPLANTATION

Source text for Eikon:  ID:nBw2WlyRfa 
Further company coverage:  ALSEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Sensorion SA

See all news